The Full Wiki

Frederick K. Goodwin: Wikis

Advertisements
  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Frederick K. Goodwin
Born April 21, 1936 (1936-04-21) (age 73)
Cincinnati, Ohio
Occupation Psychiatrist, Research Professor
Spouse(s) Rosemary Goodwin, MSW
Website
[1]

Frederick K. Goodwin is a psychiatrist and research professor of psychiatry at George Washington University. He is the director of the Psychopharmacology Research Center and the Center on Neuroscience, Medical Progress, and Society at the George Washington University Medical Center. He is a specialist in Bipolar disorder, also known as manic-depressive illness .[1]

Goodwin received his M.D. from St. Louis University, and was a psychiatric resident at the University of North Carolina in Chapel Hill. Before moving to Georgetown, Goodwin was director of the National Institute of Mental Health (NIMH), from 1981 to 1988. Earlier, he was head of the Alcohol, Drug Abuse, and Mental Health Administration. Goodwin joined the NIMH in 1965. He is known in particular for having been the first to report a controlled study on the antidepressant effects of lithium.[1]

He is a member of the Institute of Medicine of the National Academy of Sciences and a fellow of the ACNP. He is a founder of the journal Psychiatry Research, and on the editorial boards of a number of other journals. He was president of the Psychiatric Research Society, elected in 1998.[1]

Goodwin joined the NIMH in 1965. s a member of the Institute of Medicine of the National Academy of Sciences and a fellow of the ACNP. He is a founder of the journal Psychiatry Research, and on the editorial boards of a number of other journals. He was president of the Psychiatric Research Society, elected in 1998.[1]

Dr. Goodwin is a recipient of the major research awards in his field including the Hofheimer Prize from the American Psychiatric Association, the International Anna-Monika Prize for Research in Depression, the Edward A. Strecker Award, the Lieber Prize from NARSAD, the McAlpin Award, the Distinguished Service Award from NAMI, and the Research Award from the American Foundation for Suicide Prevention. He was the first recipient of the Psychiatrist of the Year from Psychiatric Times, and the Fawcett Humanitarian Award of the NDMDA. In 1998 he was elected and served as President of the Psychiatric Research Society.

Contents

The Infinite Mind and Controversy

In addition to his work at The George Washington University Medical Center and his private practice, Dr. Goodwin had been the host of the award winning radio show "The Infinite Mind". Started in 1997, the show ran every Sunday on NPR and other radio outlets. The show won more than 60 journalism awards over 10 years and was considered as “public radio’s most honored and listened to health and science program". Goodwin's acceptance from 2000 to 2008 of $1.2 million in speaking fees from GlaxoSmithKline was disclosed by Senator Charles Grassley[2] and reported in a New York Times article on Nov. 21, 2008. This income, and the resulting conflict of interest, was not disclosed to the producers of the program, nor NPR. [3] While the program, which was independently produced and distributed, was slated to end its production at the end of 2008, NPR cancelled the broadcast of the show on its Sirius Satellite channel. [1]

Awards

Publications

With Kay Redfield Jamison, Goodwin wrote Manic-Depressive Illness, the first psychiatric text to win the "Best Medical Book" award from the Association of American Publishers.

See also

References

  1. ^ a b c d e http://www.drgoodwin.com/bio.html Accessed on 31-05-08
  2. ^ http://frwebgate4.access.gpo.gov/cgi-bin/PDFgate.cgi?WAISdocID=633727474515+0+2+0&WAISaction=retrieve
  3. ^ http://www.nytimes.com/2008/11/22/health/22radio.html?hp
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message